LRRC75A and cancer: When comparing brain organoids of controls before (CON) and after (CON_Dexa) DMX treatment, LRRC75A expression was reduced by fc 2.70 in the CON_Dexa group, while HSPA6 (cluster 10 [cancer cells]) and PMCH (cluster 9 [Schwann precursor cells]) expressions increased by fc 2.24 and fc 2.23, respectively.